Concurrent Technologies PLC
7 March 2000
Concurrent Technologies Plc
£2 million contract
Concurrent Technologies Plc, which designs, produces and
markets single board computers based on Multibus II, VME &
CompactPCI, announces that Switching Test Solutions AG, a
subsidiary of Wavetek Wandel Goltermann and TTC, have
awarded Concurrent Technologies with a further contract to
design and manufacture a next generation processor board for
their Telecom Test Systems. This contract is expected to
generate production orders in the region of £2 million per
year over the next 3 years, and follows on from the existing
contract.
Michael Collins, Chairman, commented:
'This further order confirms the potential of the Company.
The Board approved a sales budget for 2000 in excess of
£10,000,000 and I am very confident that we will achieve
this. Orders remain buoyant and the new product ranges have
been well received.'
Enquiries:
Concurrent Technologies Plc Tel. No.01206 752626
Glen Fawcett, Managing Director
College Hill Tel. No.0171 457 2020
Michael Padley / Nicholas Nelson
Copies of this announcement will be available from the
Company's Registered Office: 4, Gilberd Court, Newcomen Way,
Colchester, Essex. CO4 4WN for a period of 14 days from the
date of the announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.